U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 872 records

Showing results for "alkaloid".

  1. FDA updates vinca alkaloid labeling for preparation in intravenous infusion bags only. | PSNet

    psnet.ahrq.gov/issue/fda-updates-vinca-alkaloid-labeling-preparation-intravenous-infusion-bags-only
    January 19, 2011 - Press Release/Announcement FDA updates vinca alkaloid labeling for preparation in … Vinca alkaloid misadministration is a  persistent problem  that results in patient harm and death.

  2. Vincristine (and other vinca alkaloids) should only be given intravenously via a minibag. | PSNet

    psnet.ahrq.gov/issue/vincristine-and-other-vinca-alkaloids-should-only-be-given-intravenously-minibag
    September 20, 2023 - March 17, 2021 FDA updates vinca alkaloid labeling for preparation in intravenous infusion

  3. Preventing vincristine administration errors. | PSNet

    psnet.ahrq.gov/issue/preventing-vincristine-administration-errors
    April 26, 2023 - December 22, 2021 FDA updates vinca alkaloid labeling for preparation in intravenous

  4. Identifying systems failures in the pathway to a catastrophic event: an analysis of national incident report data relating to vinca alkaloids. | PSNet

    psnet.ahrq.gov/issue/identifying-systems-failures-pathway-catastrophic-event-analysis-national-incident-report
    August 27, 2014 - Although there have been no reported accidental spinal injection of a vinca alkaloid in the United … March 17, 2021 FDA updates vinca alkaloid labeling for preparation in intravenous infusion

  5. Death and neurological devastation from intrathecal vinca alkaloids: prepared in syringes = 120; prepared in minibags = 0. | PSNet

    psnet.ahrq.gov/issue/death-and-neurological-devastation-intrathecal-vinca-alkaloids-prepared-syringes-120-prepared
    October 02, 2013 - December 22, 2021 FDA updates vinca alkaloid labeling for preparation in intravenous

  6. Global Patient Safety Challenge NewsAlert. | PSNet

    psnet.ahrq.gov/issue/global-patient-safety-challenge-newsalert
    June 03, 2020 - Newsletter/Journal Global Patient Safety Challenge NewsAlert. Citation Text: Geneva, Switzerland: World Alliance for Patient Safety, World Health Organization. 2006-2007. Copy Citation Save Save to your library Print Share Facebook Twitter …

  7. Sentinel Event Alert 63: optimizing smart infusion pump safety with DERS. | PSNet

    psnet.ahrq.gov/issue/sentinel-event-alert-63-optimizing-smart-infusion-pump-safety-ders
    November 08, 2023 - February 24, 2021 FDA updates vinca alkaloid labeling for preparation in intravenous

  8. Acute Treatment for Episodic Migraine: Surveillance Report 2 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
    June 01, 2022 - *" or "clavines alkaloid*" or Dihydroergocornine* or Dihydroergocristine* or Dihydroergocryptine* or … *" or "ergot drug*" or "ergot medication*" or Ergotamine* or Ergotamines or "ergotoxine alkaloid*" or … "ergots alkaloid*" or Lisuride* or "Lysergic Acid" or "Lysergic Acid Diethylamide*" or Metergoline* … *" or "clavines alkaloid*" or Dihydroergocornine* or Dihydroergocristine* or Dihydroergocryptine* or … "ergots alkaloid*" or Lisuride* or "Lysergic Acid" or "Lysergic Acid Diethylamide*" or Metergoline

  9. Acute Treatment for Episodic Migraine: Surveillance Report 2 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/episodic-migraine-surveillance-report-2.pdf
    June 01, 2022 - *" or "clavines alkaloid*" or Dihydroergocornine* or Dihydroergocristine* or Dihydroergocryptine* or … *" or "ergot drug*" or "ergot medication*" or Ergotamine* or Ergotamines or "ergotoxine alkaloid*" or … "ergots alkaloid*" or Lisuride* or "Lysergic Acid" or "Lysergic Acid Diethylamide*" or Metergoline* … *" or "clavines alkaloid*" or Dihydroergocornine* or Dihydroergocristine* or Dihydroergocryptine* or … "ergots alkaloid*" or Lisuride* or "Lysergic Acid" or "Lysergic Acid Diethylamide*" or Metergoline

  10. FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy. | PSNet

    psnet.ahrq.gov/issue/fda-safety-communication-caution-when-using-robotically-assisted-surgical-devices-womens
    September 01, 2021 - October 21, 2009 FDA updates vinca alkaloid labeling for preparation in intravenous infusion … February 10, 2021 FDA updates vinca alkaloid labeling for preparation in intravenous

  11. Use purple bracelets or wristbands only for do not resuscitate status - letter to industry. | PSNet

    psnet.ahrq.gov/issue/use-purple-bracelets-or-wristbands-only-do-not-resuscitate-status-letter-industry
    July 21, 2021 - February 17, 2021 FDA updates vinca alkaloid labeling for preparation in intravenous … February 10, 2021 FDA updates vinca alkaloid labeling for preparation in intravenous

  12. Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication. | PSNet

    psnet.ahrq.gov/issue/potential-medication-overdose-enfit-low-dose-tip-syringe-fda-safety-communication
    August 20, 2021 - November 7, 2012 FDA updates vinca alkaloid labeling for preparation in intravenous infusion … February 10, 2021 FDA updates vinca alkaloid labeling for preparation in intravenous

  13. FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management. | PSNet

    psnet.ahrq.gov/issue/fda-safety-communication-use-caution-implanted-pumps-intrathecal-administration-medicines
    February 07, 2018 - August 20, 2021 FDA updates vinca alkaloid labeling for preparation in intravenous infusion … February 10, 2021 FDA updates vinca alkaloid labeling for preparation in intravenous

  14. New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients. | PSNet

    psnet.ahrq.gov/issue/new-dosing-recommendations-prevent-potential-valcyte-valganciclovir-overdose-pediatric
    August 11, 2010 - February 10, 2021 FDA updates vinca alkaloid labeling for preparation in intravenous … February 10, 2021 FDA updates vinca alkaloid labeling for preparation in intravenous

  15. Shelhigh, Inc. implantable medical devices. | PSNet

    psnet.ahrq.gov/issue/shelhigh-inc-implantable-medical-devices
    June 03, 2015 - February 10, 2021 FDA updates vinca alkaloid labeling for preparation in intravenous … February 10, 2021 FDA updates vinca alkaloid labeling for preparation in intravenous

  16. Fluorouracil Incident Root Cause Analysis Report. | PSNet

    psnet.ahrq.gov/issue/fluorouracil-incident-root-cause-analysis-report
    July 28, 2010 - April 21, 2021 FDA updates vinca alkaloid labeling for preparation in intravenous infusion

  17. SRDR - Systematic Review Data Repository |

    srdr.ahrq.gov/projects/1671/studies/196394
    January 01, 2018 - Select a Topic: User Home Screen Extraction Forms Project Creation Study Creation Preview Pages Other Your Feedback: Submit Reset Cancel Study Preview Study Title and Description Intranasal sumatriptan for acute migraine attacks: a systematic review and meta-analysis. Key Questions Addressed …

  18. SRDR - Systematic Review Data Repository |

    srdr.ahrq.gov/projects/1671/studies/196176
    Select a Topic: User Home Screen Extraction Forms Project Creation Study Creation Preview Pages Other Your Feedback: Submit Reset Cancel Study Preview Study Title and Description Treatment of migraine with intramuscular chlorpromazine. Key Questions Addressed 2 KQ2a. What is the comparative e…

  19. SRDR - Systematic Review Data Repository |

    srdr.ahrq.gov/projects/1671/studies/196179
    Select a Topic: User Home Screen Extraction Forms Project Creation Study Creation Preview Pages Other Your Feedback: Submit Reset Cancel Study Preview Study Title and Description The effect of intravenous verapamil on acute migraine headache. Key Questions Addressed 2 KQ2a. What is the compar…

  20. SRDR - Systematic Review Data Repository |

    srdr.ahrq.gov/projects/1671/studies/196163
    January 01, 1992 - Select a Topic: User Home Screen Extraction Forms Project Creation Study Creation Preview Pages Other Your Feedback: Submit Reset Cancel Study Preview Study Title and Description Ketoprofen and ergotamine in acute migraine. Key Questions Addressed 2 KQ2a. What is the comparative effectiveness…
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

psnet.ahrq.gov (601)

srdr.ahrq.gov (139)

effectivehealthcare.ahrq.gov (43)

www.ahrq.gov (18)

hcup-us.ahrq.gov (13)

ce.effectivehealthcare.ahrq.gov (11)

ahrqpubs.ahrq.gov (4)

cahps.ahrq.gov (4)

healthcare411.ahrq.gov (4)

monahrq.ahrq.gov (4)

patientregistry.ahrq.gov (4)

pbrn.ahrq.gov (4)

pcmh.ahrq.gov (4)

talkingquality.ahrq.gov (4)

digital.ahrq.gov (2)

hcupnet.ahrq.gov (2)

www.cpsi.ahrq.gov (2)

cds.ahrq.gov (1)

datatools.ahrq.gov (1)

teamstepps.ahrq.gov (1)

www.cahps.ahrq.gov (1)

www.healthcare411.ahrq.gov (1)

www.innovations.ahrq.gov (1)

www.monahrq.ahrq.gov (1)

www.qualitymeasures.ahrq.gov (1)

www.talkingquality.ahrq.gov (1)